List of Tables
Table 1: NAFLD Definitions and Phenotypes 10
Table 2: Major Symptoms of NASH 11
Table 3: Etiologies of NASH 12
Table 4: Histopathological Abnormalities in NASH 17
Table 5 NAFLD Activity Score and Staging System 20
Table 6: Therapeutic Management in NASH 24
Table 7: NASH Therapeutics Market, Global, Licensing Deals Valued $100m and Above, 2007–2018 86
Table 8: NASH Therapeutics Market, Global, Co-development Deals with Deal Value 10 and above, 2007–2018 92
Table 9: NASH Therapeutics Market, Global, All Pipeline Products, Discovery, 2018 93
Table 10: NASH Therapeutics Market, Global, All Pipeline Products, Preclinical, 2018 95
Table 11: NASH Therapeutics Market, Global, All Pipeline Products, IND/CTA-filed, 2018 98
Table 12: NASH Therapeutics Market, Global, All Pipeline Products, Phase I, 2018 99
Table 13: NASH Therapeutics Market, Global, All Pipeline Products, Phase II, 2018 100
Table 14: NASH Therapeutics Market, Global, All Pipeline Products, Phase III, 2018 101
Table 15: NASH Therapeutics Market, APAC, Market Forecast, 2017–2024 101
Table 16: NASH Therapeutics Market, India, Market Forecast, 2017–2024 102
Table 17: NASH Therapeutics Market, China, Market Forecast, 2017–2024 102
Table 18: NASH Therapeutics Market, Australia, Market Forecast, 2017–2024 103
Table 19: NASH Therapeutics Market, South Korea, Market Forecast, 2017–2024 103
Table 20: NASH Therapeutics Market, Japan, Market Forecast, 2017–2024 104